Latest news

February 6, 2024

Strategikon Closes Series A1 Funding Round to Modernize Clinical Trials Business Operations Worldwide

Read more
February 2, 2024

Challenge pour la Qualité de vie du patient 2024, l’appel à projets est ouvert

Read more
January 29, 2024

TransCode Therapeutics and Debiopharm Announce Collaboration to Develop Targeted Nucleic Acid Therapeutics for Cancer

Read more
January 25, 2024

Genialis and Debiopharm Set Up Biomarker Discovery Collaboration

Read more
January 10, 2024

Debiopharm and Forge Strategic Partnership to Propel Cancer Drug Development

Read more
January 9, 2024

MedaSystems Secures Additional Funding from Debiopharm Innovation Fund to Accelerate Global Access to Pre-approval Treatment

Read more
January 8, 2024

Debiopharm Extends SunRock Biopharma Partnership for Antibody-Drug Conjugates Targeting HER3 in EGFR Mutated Cancers

Read more
January 5, 2024

Debiopharm and Repare Therapeutics Partner to Explore the Synthetic Lethal Combination of PKMYT1 and WEE1 Inhibition in Cancer

Read more
December 12, 2023

Le 8e Challenge Qualité de vie du patient récompense BOOTIS.CH, plateforme d’organisation de voyages pour les personnes souffrant d’un handicap

Read more

Stay informed

Don't miss any latest news and announcements on Debiopharm Investment, subscribe to our newsletter.